U.S. Markets open in 9 hrs 12 mins
  • S&P Futures

    4,574.50
    -1.25 (-0.03%)
     
  • Dow Futures

    34,637.00
    +15.00 (+0.04%)
     
  • Nasdaq Futures

    15,972.00
    -16.50 (-0.10%)
     
  • Russell 2000 Futures

    2,198.60
    -6.60 (-0.30%)
     
  • Crude Oil

    67.76
    +1.26 (+1.89%)
     
  • Gold

    1,772.80
    +10.10 (+0.57%)
     
  • Silver

    22.41
    +0.09 (+0.42%)
     
  • EUR/USD

    1.1301
    -0.0005 (-0.0452%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3290
    -0.0012 (-0.0904%)
     
  • USD/JPY

    113.2070
    -0.0020 (-0.0018%)
     
  • BTC-USD

    56,608.66
    -277.41 (-0.49%)
     
  • CMC Crypto 200

    1,440.91
    +2.03 (+0.14%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,905.29
    +151.92 (+0.55%)
     

The Independent Director of AMERISAFE, Inc. (NASDAQ:AMSF), Philip Garcia, Just Bought 20% More Shares

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Investors who take an interest in AMERISAFE, Inc. (NASDAQ:AMSF) should definitely note that the Independent Director, Philip Garcia, recently paid US$56.49 per share to buy US$157k worth of the stock. That's a very solid buy in our book, and increased their holding by a noteworthy 20%.

Check out our latest analysis for AMERISAFE

The Last 12 Months Of Insider Transactions At AMERISAFE

Over the last year, we can see that the biggest insider purchase was by Independent Director Sean Traynor for US$509k worth of shares, at about US$63.59 per share. That means that even when the share price was higher than US$56.39 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

While AMERISAFE insiders bought shares during the last year, they didn't sell. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does AMERISAFE Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 1.9% of AMERISAFE shares, worth about US$20m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Do The AMERISAFE Insider Transactions Indicate?

The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. Given that insiders also own a fair bit of AMERISAFE we think they are probably pretty confident of a bright future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. For instance, we've identified 2 warning signs for AMERISAFE (1 makes us a bit uncomfortable) you should be aware of.

Of course AMERISAFE may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.